Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Nat Prod ; 79(8): 1982-9, 2016 08 26.
Artículo en Inglés | MEDLINE | ID: mdl-27447544

RESUMEN

Harnessing the inherent biological relevance of natural products requires a method for the recognition of biological effects that may subsequently lead to the discovery of particular targets. An unbiased multidimensional profiling method was used to examine the activities of natural products on primary cells derived from a Parkinson's disease patient. The biological signature of 482 natural products was examined using multiparametric analysis to investigate known cellular pathways and organelles implicated in Parkinson's disease such as mitochondria, lysosomes, endosomes, apoptosis, and autophagy. By targeting several cell components simultaneously the chance of finding a phenotype was increased. The phenotypes were then clustered using an uncentered correlation. The multidimensional phenotypic screening showed that all natural products, in our screening set, were biologically relevant compounds as determined by an observed phenotypic effect. Multidimensional phenotypic screening can predict the cellular function and subcellular site of activity of new compounds, while the cluster analysis provides correlation with compounds with known mechanisms of action. This study reinforces the value of natural products as biologically relevant compounds.


Asunto(s)
Productos Biológicos/farmacología , Enfermedad de Parkinson , Bibliotecas de Moléculas Pequeñas , Apoptosis/efectos de los fármacos , Humanos , Estructura Molecular
2.
Proc Natl Acad Sci U S A ; 110(7): E593-601, 2013 Feb 12.
Artículo en Inglés | MEDLINE | ID: mdl-23359713

RESUMEN

The epigenetic regulator Bmi1 controls proliferation in many organs. Reexpression of cell cycle proteins such as cyclin-dependent kinases (CDKs) is a hallmark of neuronal apoptosis in neurodegenerative diseases. Here we address the potential role of Bmi1 as a key regulator of cell cycle proteins during neuronal apoptosis. We show that several cell cycle proteins are expressed in different models of retinal degeneration and required in the Rd1 photoreceptor death process. Deleting E2f1, a downstream target of CDKs, provided temporary protection in Rd1 mice. Most importantly, genetic ablation of Bmi1 provided extensive photoreceptor survival and improvement of retinal function in Rd1 mice, mediated by a decrease in cell cycle markers and regulators independent of p16(Ink4a) and p19(Arf). These data reveal that Bmi1 controls the cell cycle-related death process, highlighting this pathway as a promising therapeutic target for neuroprotection in retinal dystrophies.


Asunto(s)
Apoptosis/fisiología , Proteínas de Ciclo Celular/metabolismo , Epigénesis Genética/fisiología , Regulación de la Expresión Génica/fisiología , Complejo Represivo Polycomb 1/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Degeneración Retiniana/metabolismo , Análisis de Varianza , Animales , Factor de Transcripción E2F1/metabolismo , Epigénesis Genética/genética , Regulación de la Expresión Génica/genética , Técnicas Histológicas , Ratones , Ratones Noqueados , Microscopía Fluorescente , Complejo Represivo Polycomb 1/genética , Proteínas Proto-Oncogénicas/genética
3.
J Nat Prod ; 75(12): 2200-8, 2012 Dec 28.
Artículo en Inglés | MEDLINE | ID: mdl-23215348

RESUMEN

Three new cyclic depsipeptides, neamphamides B (2), C (3), and D (4), were isolated from the Australian sponge Neamphius huxleyi. The planar structural characterization of these molecules was elucidated using 2D NMR experiments and ESI-FTICR-MS(n). Their configurations were determined by Marfey's method and J-based NMR analysis. These new metabolites inhibited the growth of human cell lines (A549, HeLa, LNCaP, PC3, and NFF) with IC(50) values ranging from 88 to 370 nM. However, neamphamide D causes A549 cell proliferation at subcytotoxic doses and should be treated cautiously as a cytotoxic compound.


Asunto(s)
Antineoplásicos/aislamiento & purificación , Antineoplásicos/farmacología , Depsipéptidos/aislamiento & purificación , Depsipéptidos/farmacología , Poríferos/química , Animales , Antineoplásicos/química , Australia , Depsipéptidos/química , Células HeLa , Humanos , Biología Marina , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular
4.
Planta Med ; 78(7): 730-6, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22354391

RESUMEN

A new glucoalkaloid, vespertilioside, together with three known alkaloids, including 11- ß-methoxyglucoerysovine, erysotrine, and hypaphorine, were isolated from the fruits of E. vespertilio Benth. In addition, three known isoflavonoids, including phaseollin, alpiniumisoflavone, and phaseollidin, were identified from the plant stems. The structures of compounds were determined by 1D/2D NMR and mass experiments. The cytotoxic activity of all compounds was evaluated against a metastatic prostate cancer cell line (PC3) and neonatal foreskin fibroblast (NFF) using a real-time label-free cell analyser. Among the tested compounds, phaseollidin showed cytotoxic activities against PC3 (IC (50) = 8.83 ± 1.87 µM) and NFF (0.64 ± 0.37 µM) cell lines.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Citotoxinas/aislamiento & purificación , Erythrina/química , Isoflavonas/farmacología , Neoplasias de la Próstata/tratamiento farmacológico , Pterocarpanos/farmacología , Alcaloides/aislamiento & purificación , Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/aislamiento & purificación , Australia , Adhesión Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Citotoxinas/química , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Fibroblastos/efectos de los fármacos , Fibroblastos/patología , Flavonoides/aislamiento & purificación , Prepucio/citología , Frutas/química , Humanos , Recién Nacido , Concentración 50 Inhibidora , Isoflavonas/química , Isoflavonas/aislamiento & purificación , Masculino , Corteza de la Planta/química , Tallos de la Planta/química , Pterocarpanos/química , Pterocarpanos/aislamiento & purificación , Semillas/química , Relación Estructura-Actividad
5.
Sci Rep ; 7(1): 391, 2017 03 24.
Artículo en Inglés | MEDLINE | ID: mdl-28341829

RESUMEN

USP9X, is highly expressed in neural progenitors and, essential for neural development in mice. In humans, mutations in USP9X are associated with neurodevelopmental disorders. To understand USP9X's role in neural progenitors, we studied the effects of altering its expression in both the human neural progenitor cell line, ReNcell VM, as well as neural stem and progenitor cells derived from Nestin-cre conditionally deleted Usp9x mice. Decreasing USP9X resulted in ReNcell VM cells arresting in G0 cell cycle phase, with a concomitant decrease in mTORC1 signalling, a major regulator of G0/G1 cell cycle progression. Decreased mTORC1 signalling was also observed in Usp9x-null neurospheres and embryonic mouse brains. Further analyses revealed, (i) the canonical mTORC1 protein, RAPTOR, physically associates with Usp9x in embryonic brains, (ii) RAPTOR protein level is directly proportional to USP9X, in both loss- and gain-of-function experiments in cultured cells and, (iii) USP9X deubiquitlyating activity opposes the proteasomal degradation of RAPTOR. EdU incorporation assays confirmed Usp9x maintains the proliferation of neural progenitors similar to Raptor-null and rapamycin-treated neurospheres. Interestingly, loss of Usp9x increased the number of sphere-forming cells consistent with enhanced neural stem cell self-renewal. To our knowledge, USP9X is the first deubiquitylating enzyme shown to stabilize RAPTOR.


Asunto(s)
Autorrenovación de las Células , Diana Mecanicista del Complejo 1 de la Rapamicina/metabolismo , Células-Madre Neurales/metabolismo , Proteína Reguladora Asociada a mTOR/metabolismo , Ubiquitina Tiolesterasa/metabolismo , Animales , Puntos de Control del Ciclo Celular , Endopeptidasas/metabolismo , Células HEK293 , Humanos , Ratones , Proteolisis , Transducción de Señal
6.
J Neurosci ; 25(24): 5774-83, 2005 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-15958744

RESUMEN

The polycomb transcriptional repressor Bmi1 promotes cell cycle progression, controls cell senescence, and is implicated in brain development. Loss of Bmi1 leads to a decreased brain size and causes progressive ataxia and epilepsy. Recently, Bmi1 was shown to control neural stem cell (NSC) renewal. However, the effect of Bmi1 loss on neural cell fate in vivo and the question whether the action of Bmi1 was intrinsic to the NSCs remained to be investigated. Here, we show that Bmi1 is expressed in the germinal zone in vivo and in NSCs as well as in progenitors proliferating in vitro, but not in differentiated cells. Loss of Bmi1 led to a decrease in proliferation in zones known to contain progenitors: the newborn cortex and the newborn and adult subventricular zone. This decrease was accentuated in vitro, where we observed a drastic reduction in NSC proliferation and renewal because of NSC-intrinsic effects of Bmi1 as shown by the means of RNA interference. Bmi1(-/-) mice also presented more astrocytes at birth, and a generalized gliosis at postnatal day 30. At both stages, colocalization of bromodeoxyuridine and GFAP demonstrated that Bmi1 loss did not prevent astrocyte precursor proliferation. Supporting these observations, Bmi1(-/-) neurospheres generate preferentially astrocytes probably attributable to a different responsiveness to environmental factors. Bmi1 is therefore necessary for NSC renewal in a cell-intrinsic mode, whereas the altered cell pattern of the Bmi1(-/-) brain shows that in vivo astrocyte precursors can proliferate in the absence of Bmi1.


Asunto(s)
Astrocitos/citología , Neuronas/fisiología , Proteínas Nucleares/deficiencia , Proteínas Nucleares/genética , Proteínas Proto-Oncogénicas/deficiencia , Proteínas Proto-Oncogénicas/genética , Proteínas Represoras/genética , Células Madre/citología , Animales , Animales Recién Nacidos , Secuencia de Bases , Núcleo Caudado/fisiología , Diferenciación Celular , División Celular , Corteza Cerebral/fisiología , Cartilla de ADN , Regulación del Desarrollo de la Expresión Génica , Tamización de Portadores Genéticos , Gliosis/genética , Etiquetado Corte-Fin in Situ , Ratones , Ratones Noqueados , Neuronas/citología , Complejo Represivo Polycomb 1 , Putamen , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
7.
Adv Exp Med Biol ; 572: 209-15, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17249577

RESUMEN

Retinitis pigmentosa (RP) is a heterogeneous group of genetic disorders leading to blindness, which remain untreatable at present. Rd1 mice represent a recognized model of RP, and so far only GDNF treatment provided a slight delay in the retinal degeneration in these mice. Bmi1, a transcriptional repressor, has recently been shown to be essential for neural stem cell (NSC) renewal in the brain, with an increased appearance of glial cells in vivo in Bmi1 knockout (Bmi1-/-) mice. One of the roles of glial cells is to sustain neuronal function and survival. In the view of a role of the retinal Miller glia as a source of neural protection in the retina, the increased astrocytic population in the Bmi1-/- brain led us to investigate the effect of Bmi1 loss in Rd1 mice. We observed an increase of Müller glial cells in Rd1-Bmi1-/- retinas compared to Rd1. Moreover, Rd1-Bmi1-/- mice showed 7-8 rows of photoreceptors at 30 days of age (P30), while in Rd1 littermates there was a complete disruption of the outer nuclear layer (ONL). Preliminary ERG results showed a responsiveness of Rd1-Bmi1-/- mice in scotopic vision at P35. In conclusion, Bmi1 loss prevented, or rescued, photoreceptors from degeneration to an unanticipated extent in Rd1 mice. In this chapter, we will first provide a brief review of our work on the cortical NSCs and introduce the Bmi1 oncogene, thus offering a rational to our observations on the retina.


Asunto(s)
Proteínas Nucleares/genética , Proteínas Proto-Oncogénicas/genética , Proteínas Represoras/genética , Degeneración Retiniana/genética , Animales , Proliferación Celular , Modelos Animales de Enfermedad , Electrorretinografía , Ratones , Ratones Noqueados , Ratones Transgénicos , Modelos Biológicos , Neuroglía/metabolismo , Neuronas/citología , Fármacos Neuroprotectores/farmacología , Complejo Represivo Polycomb 1 , Retina/metabolismo , Degeneración Retiniana/metabolismo , Células Madre/citología
8.
Chem Biol Drug Des ; 86(4): 400-9, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25557046

RESUMEN

DNA synthesis is a fundamental biological process central to all proliferating cells, and the design of small molecule probes that allow detection of this DNA is important for many applications. 5-Ethynyl-2'-deoxyuridine, known as EdU, has become a workhorse for metabolic labeling of DNA in mammalian cells, followed by bioconjugation to a small molecule fluorescent azide using copper-catalyzed azide-alkyne cycloaddition (CuAAC), click chemistry, to allow detection. In this study, we demonstrate that a cyclosal phosphotriester pronucleotide analog of EdU is suitable for metabolic incorporation into DNA of proliferating cells and subsequent labeling by CuAAC. This analog has two advantages over EdU; first, by delivering EdU with a preinstalled 5'-monophosphate moiety, it bypasses the need for thymidine kinase processing, and second, the increased lipophilicity compared to EdU may enable passive diffusion across the cell membrane and may circumvent the reliance on nucleoside active transport mechanisms for cellular uptake. These advantages pave the way for the development of additional novel pronucleotides to widen experimental opportunities for future bioconjugation applications involving cellular DNA.


Asunto(s)
Proliferación Celular/fisiología , ADN/metabolismo , Desoxiuridina/análogos & derivados , Coloración y Etiquetado/métodos , Células Madre/metabolismo , Células Cultivadas , Desoxiuridina/síntesis química , Desoxiuridina/química , Desoxiuridina/farmacología , Humanos , Células Madre/citología
9.
PLoS One ; 7(9): e46134, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23029409

RESUMEN

Fenestrations are transcellular pores in endothelial cells that facilitate transfer of substrates between blood and the extravascular compartment. In order to understand the regulation and formation of fenestrations, the relationship between membrane rafts and fenestrations was investigated in liver sinusoidal endothelial cells where fenestrations are grouped into sieve plates. Three dimensional structured illumination microscopy, scanning electron microscopy, internal reflectance fluorescence microscopy and two-photon fluorescence microscopy were used to study liver sinusoidal endothelial cells isolated from mice. There was an inverse distribution between sieve plates and membrane rafts visualized by structured illumination microscopy and the fluorescent raft stain, Bodipy FL C5 ganglioside GM1. 7-ketocholesterol and/or cytochalasin D increased both fenestrations and lipid-disordered membrane, while Triton X-100 decreased both fenestrations and lipid-disordered membrane. The effects of cytochalasin D on fenestrations were abrogated by co-administration of Triton X-100, suggesting that actin disruption increases fenestrations by its effects on membrane rafts. Vascular endothelial growth factor (VEGF) depleted lipid-ordered membrane and increased fenestrations. The results are consistent with a sieve-raft interaction, where fenestrations form in non-raft lipid-disordered regions of endothelial cells once the membrane-stabilizing effects of actin cytoskeleton and membrane rafts are diminished.


Asunto(s)
Estructuras de la Membrana Celular/ultraestructura , Células Endoteliales/ultraestructura , Hígado/citología , Microdominios de Membrana/ultraestructura , Actinas/metabolismo , Actinas/ultraestructura , Animales , Estructuras de la Membrana Celular/efectos de los fármacos , Estructuras de la Membrana Celular/metabolismo , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Cetocolesteroles/farmacología , Hígado/efectos de los fármacos , Hígado/embriología , Microdominios de Membrana/química , Microdominios de Membrana/efectos de los fármacos , Microdominios de Membrana/metabolismo , Ratones , Ratones Endogámicos C57BL , Micromanipulación , Octoxinol/farmacología , Factor A de Crecimiento Endotelial Vascular/metabolismo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda